SCHEMBL20312366

SCHEMBL20312366

CC(C)OB(OC(C)C)c1ccccc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
ALOX15 P16050 2/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
ADRA2B P18089 1/20 0.35
PTGS1 P23219 1/20 0.35
ADRA2C P18825 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 2/20 0.32
GAA P10253 2/20 0.32
KMT2A Q03164 2/20 0.32
USP2 O75604 1/20 0.32
KEAP1 Q14145 1/20 0.31
TSHR P16473 3/20 0.31
PIK3CA P42336 1/20 0.31
CFTR P13569 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12424043 0.76 ALDH1A1 (0.44) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
SCHEMBL5952621 0.75 LMNA (0.36) CYP3A4ALDH1A1L3MBTL1TSHRMAPT
SCHEMBL28360418 0.73 CYP3A4 (0.43) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
SCHEMBL15892295 0.72 ALDH1A1 (0.38) CYP3A4ALOX15SMN1; SMN2ALDH1A1TDP1
SCHEMBL5951630 0.72 KDM4E (0.39) CYP3A4ALOX15ALDH1A1TDP1PTGS1
SCHEMBL20312369 0.72 MAPT (0.34) SMN1; SMN2ALDH1A1TDP1L3MBTL1GAA
Hydrochloric Acid SCHEMBL28507710 0.71 CYP3A4 (0.41) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
SCHEMBL28620104 0.71 CYP3A4 (0.41) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
Water SCHEMBL28854478 0.71 CYP3A4 (0.41) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
SCHEMBL2400555 0.69 ORAI1 (0.40) CYP3A4ALOX15SMN1; SMN2ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate TOKYO OHKA KOGYO CO, LTD. (JP) 2019-12-10 US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE SLC43A1, SAMHD1, SNRPD2 CYP3A4 2433/4885ALOX15 4044/4885CASP1 4359/4885
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate SLC43A1, SAMHD1, SNRPD2 CYP3A4 2433/4885ALOX15 4044/4885CASP1 4359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.